Skip to main navigation Skip to search Skip to main content

Secondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patients

  • M. G. Rock
  • , F. H. Sim
  • , K. K. Unni
  • , G. A. Witrak
  • , F. J. Frassica
  • , M. F. Schray
  • , J. W. Beabout
  • , D. C. Dahlin

Research output: Contribution to journalArticlepeer-review

Abstract

Twenty-six patients who had a malignant giant-cell tumor of bone - a sarcoma either juxtaposed to a zone of typical benign giant-cell tumor or occurring at the site of a previously documented benign giant-cell tumor - have been seen at the Mayo Clinic. Of the twenty-six tumors, nineteen were secondary to a previous attempt at local control of a benign giant-cell tumor. All but one of these nineteen patients with a secondary tumor had received therapeutic irradiation four to thirty-nine years earlier. The nature and duration of the symptoms and the sites of predilection of the malignant giant-cell tumors were the same as for benign giant-cell tumor. Fibrosarcoma occurred three times as frequently as osteosarcoma. The best results of treatment of the secondary sarcoma were obtained with early ablation.

Original languageEnglish (US)
Pages (from-to)1073-1079
Number of pages7
JournalJournal of Bone and Joint Surgery - Series A
Volume68
Issue number7
DOIs
StatePublished - 1986
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Secondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patients'. Together they form a unique fingerprint.

Cite this